FI834451A7 - Foerfarande foer framstaellning av nya substituerade 1,4-dihydropyridiner. - Google Patents

Foerfarande foer framstaellning av nya substituerade 1,4-dihydropyridiner. Download PDF

Info

Publication number
FI834451A7
FI834451A7 FI834451A FI834451A FI834451A7 FI 834451 A7 FI834451 A7 FI 834451A7 FI 834451 A FI834451 A FI 834451A FI 834451 A FI834451 A FI 834451A FI 834451 A7 FI834451 A7 FI 834451A7
Authority
FI
Finland
Prior art keywords
dihydropyridiner
substituerade
nya
foerfarande foer
foer framstaellning
Prior art date
Application number
FI834451A
Other languages
English (en)
Finnish (fi)
Other versions
FI834451A0 (fi
Inventor
Karl Schoenafinger
Helmut Bohn
Melitta Just
Piero Martorana
Original Assignee
Cassella Farbwerke Mainkur Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Farbwerke Mainkur Ag filed Critical Cassella Farbwerke Mainkur Ag
Publication of FI834451A0 publication Critical patent/FI834451A0/fi
Publication of FI834451A7 publication Critical patent/FI834451A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Storage Of Fruits Or Vegetables (AREA)
  • Protection Of Plants (AREA)
FI834451A 1982-12-20 1983-12-05 Foerfarande foer framstaellning av nya substituerade 1,4-dihydropyridiner. FI834451A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823247118 DE3247118A1 (de) 1982-12-20 1982-12-20 Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
FI834451A0 FI834451A0 (fi) 1983-12-05
FI834451A7 true FI834451A7 (fi) 1984-06-21

Family

ID=6181182

Family Applications (1)

Application Number Title Priority Date Filing Date
FI834451A FI834451A7 (fi) 1982-12-20 1983-12-05 Foerfarande foer framstaellning av nya substituerade 1,4-dihydropyridiner.

Country Status (20)

Country Link
US (1) US4558058A (cs)
EP (1) EP0116708B1 (cs)
JP (1) JPS59118783A (cs)
KR (1) KR840006969A (cs)
AT (1) ATE19776T1 (cs)
AU (1) AU562583B2 (cs)
CA (1) CA1194480A (cs)
CS (1) CS241144B2 (cs)
DD (1) DD215548A5 (cs)
DE (2) DE3247118A1 (cs)
DK (1) DK562683A (cs)
ES (1) ES528175A0 (cs)
FI (1) FI834451A7 (cs)
GR (1) GR79484B (cs)
HU (1) HU194556B (cs)
NO (1) NO834480L (cs)
PH (1) PH20327A (cs)
PL (1) PL140526B1 (cs)
SU (1) SU1360585A3 (cs)
ZA (1) ZA839382B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
DE3431152A1 (de) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel
DE3431862A1 (de) * 1984-08-30 1986-03-13 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US5326772A (en) * 1984-09-28 1994-07-05 Byk Gulden Lomberg Chemische Fabrik Gmbh Diaryl compounds for their use
JPS6191185A (ja) * 1984-10-11 1986-05-09 Sumitomo Seiyaku Kk 新規なオキサジアゾリル−1,4−ジヒドロピリジン誘導体
DE3443179A1 (de) * 1984-11-27 1986-05-28 Cassella Ag, 6000 Frankfurt 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung
US4650805A (en) * 1985-12-02 1987-03-17 Warner-Lambert Company 4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines and 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamines having anti-psychotic activity
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
AU1626488A (en) * 1987-03-27 1988-11-02 Byk Gulden Lomberg Chemische Fabrik Gmbh 1,4-dihydropyridine enantiomers
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
DE3807895A1 (de) * 1988-03-10 1989-09-21 Knoll Ag Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker
US5276150A (en) * 1989-05-31 1994-01-04 Fujirebio Inc. 1,4-dihydropyridine derivatives
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US6531158B1 (en) 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
US7312337B2 (en) * 2004-09-30 2007-12-25 Eastman Kodak Company Oxadiazoles and their manufacture
DE102006044696A1 (de) * 2006-09-22 2008-03-27 Bayer Healthcare Ag 3-Cyano-5-thiazaheteroaryl-dihydropyridine und ihre Verwendung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL31990A (en) * 1968-04-26 1974-05-16 Chinoin Gyogyszer Es Vegyeszet Pyridyl 1,2,4-oxadiazole derivatives,process for the preparation thereof and pharmaceutical compositions containing same
DE1963186C3 (de) * 1969-12-17 1979-02-15 Bayer Ag, 5090 Leverkusen Schwefelhaltige 1,4-Dihydropyridin-33-dicarbonsäureester
DE2005116C3 (de) * 1970-02-05 1980-02-14 Bayer Ag, 5090 Leverkusen Symmetrische 1,4-Dihydropyridin-3,5-dicarbonsäureester
CA962269A (en) * 1971-05-05 1975-02-04 Robert E. Grahame (Jr.) Thiazoles, and their use as insecticides
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
DE2747513A1 (de) * 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen
US4144343A (en) * 1978-01-04 1979-03-13 Merck & Co., Inc. Heterocycle substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3022030A1 (de) * 1980-06-12 1981-12-17 Bayer Ag, 5090 Leverkusen 4-thiazol- bzw. 4-imidazol-substituierte, 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use

Also Published As

Publication number Publication date
DD215548A5 (de) 1984-11-14
JPS59118783A (ja) 1984-07-09
PH20327A (en) 1986-12-02
DE3363545D1 (en) 1986-06-19
ES8406193A1 (es) 1984-08-01
KR840006969A (ko) 1984-12-04
PL245200A1 (en) 1985-02-27
DK562683D0 (da) 1983-12-06
CS241144B2 (en) 1986-03-13
EP0116708A1 (de) 1984-08-29
US4558058A (en) 1985-12-10
GR79484B (cs) 1984-10-30
FI834451A0 (fi) 1983-12-05
DK562683A (da) 1984-06-21
PL140526B1 (en) 1987-05-30
NO834480L (no) 1984-06-21
DE3247118A1 (de) 1984-06-20
HU194556B (en) 1988-02-29
SU1360585A3 (ru) 1987-12-15
EP0116708B1 (de) 1986-05-14
AU2253383A (en) 1984-06-28
CS961383A2 (en) 1985-07-16
AU562583B2 (en) 1987-06-11
ES528175A0 (es) 1984-08-01
ZA839382B (en) 1984-08-29
CA1194480A (en) 1985-10-01
ATE19776T1 (de) 1986-05-15

Similar Documents

Publication Publication Date Title
FI77041B (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara difosfonsyraderivat.
ATE28329T1 (de) 1,3-dioxan-5-ylalkensaeuren.
FI841759L (fi) Foerfarande foer framstaellning av nya fluoralkoxifoereningar.
FI80885B (fi) Framstaellning av nya guaninderivat.
FI841273A0 (fi) Foerfarande foer frmastaellning av nya furo-(3,4-c)- pyridinderivater.
FI844279L (fi) Foerfarande foer framstaellning av nya 6-vinyl-furo-(3,4-c)-pyridinderivat.
FI841758L (fi) Foerfarande foer framstaellning av nya tricykliska etrar.
FI834451A7 (fi) Foerfarande foer framstaellning av nya substituerade 1,4-dihydropyridiner.
FI80881B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1,5-bentsotiazepinderivat.
FI842547A0 (fi) Foerfarande foer framstaellning av nya spirosuckinimider.
FI844051L (fi) Foerfarande foer dehalogenering av 6, 6-dibrompenicillansyra-1,1-dioxid.
FI834849L (fi) Foerfarande foer framstaellning av en behaollare, saerskilt foer transformatorer.
FI73988B (fi) Foerfarande foer framstaellning av nya kardiotoniskt verkande pyridinyl-2-pyrimidinaminderivat.
FI834666A7 (fi) Foerfarande foer framstaellning av nya aralkyltriazolfoereningar.
FI840108L (fi) Foerfarande foer framstaellning av nya, terapeutiskt' anvaendbara ortokondenserade pyrrolderivat.
FI844034A7 (fi) Foerfarande foer framstaellning av nya 4-klor-furo-(3,4-c)-pyridinderivat.
FI850994A0 (fi) Foerfarande foer framstaellning av nya 1,2,4-triazacykloalkadienderivat.
FI841336A7 (fi) Foerfarande foer framstaellning av symmetriska 1,4-dihydropyridin-dikarboxyl-syraestrar.
FI841272L (fi) Nya penemfoereningar, farmaceutiska blandningar innehaollande dessa, foerfarande foer deras framstaellning.
FI833501L (fi) Foerfarande foer framstaellning av 15-cykloalifatiska haerledningar av 13,14-didehydro-karboprostacykliner
FI842389A0 (fi) Foerfarande foer framstaellning av nya bensofenoner.
FI850995L (fi) Foerfarande foer framstaellning av nya 3-merkapto-1,2,4-triazacykloalkadienderivat.
FI834183A0 (fi) Nya kefalosporiner, foerfarande foer deras framstaellning, dessa innehaollande antibakteriellt aemne, mellanprodukter daerav samt foerfarande foer framstaellning av mellanprodukterna.
FI840255L (fi) Foerfarande foer framstaellning av antihypertensiva 2-/fenetyl/-5-/(3,4-metylendioxi)- - hydroxibensyl)pyrrolidiner.
FI834789L (fi) Foerfarande foer framstaellning av 1,1- difenylpropanolderivat.

Legal Events

Date Code Title Description
FA Application withdrawn [patent]

Owner name: CASSELLA AKTIENGESELLSCHAFT